Clinical Trial Update: Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73 [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 dosimetry and preliminary clinical application study of a novel CD73-targeting probe for cancer, currently recruiting at the First Affiliated Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• CD73-targeting probe

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Malignant Tumour | EARLY_Phase 1 | Status: RECRUITING